ProQR Therapeutics (PRQR) Non-cash Items (2017 - 2024)

ProQR Therapeutics has reported Non-cash Items for 12 years, with the latest figure at $1169.1 in Q3 2025.

• Quarterly Non-cash Items rose 6.45% year-over-year to $1169.1 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4451.1 (up 100.05% YoY) and the FY2021 annual result came in at $1183.4, up 3.65% from the prior year.
• Non-cash Items improved to $1169.1 in Q3 2025 per PRQR's latest filing, from $1132.0 in the prior quarter.
• Over five years, Non-cash Items peaked at $48.0 million in Q1 2023 and troughed at -$14.5 million in Q2 2022.
• A 5-year average of -$65852.1 and a median of $1110.3 in 2022 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items sank 1220079.74% in 2022, then jumped 4277152.03% in 2023.
• Over 5 years, Non-cash Items stood at $1144.0 in 2021, then sank by 1257742.63% to -$14.4 million in 2022, then soared by 43.19% to -$8.2 million in 2023, then surged by 100.01% to $1098.2 in 2024, then grew by 6.45% to $1169.1 in 2025.
• According to Business Quant data, Non-cash Items over the past three periods registered $1169.1, $1132.0, and $1051.9 for Q3 2025, Q2 2025, and Q1 2025 respectively.